Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany

Current Medical Research and Opinion
Cristina StasiFrancesco Cipriani

Abstract

Recent introduction of direct antiviral agents (DAAs) has completely changed the scenario regarding hepatitis C virus (HCV) treatment. Certain countries' economic health programs prioritize DAAs according to specific clinical features of HCV-infected patients. The aim of this study was to define epidemiological, demographic and clinical characteristics of HCV-infected patients in the Tuscany region of central Italy. We enrolled HCV patients with chronic viral hepatitis who were referred to the outpatient services of 16 hospitals in Tuscany from 1 January 2015 to 31 December 2015. Case report forms contained patient information including main demographic data, blood chemistry data, viral hepatitis markers, instrumental evaluations (liver biopsy or transient elastometry, liver ultrasound), eligibility for DAAs, and liver transplantation or therapy already in progress. Of all patients considered, 2919 HCV patients were enrolled (mean age: 57.44 ± 15.15; 54% males, 46% females). All routes of transmission were well represented (intravenous drug use in 20.7%; nosocomial/dental care in 20.6%; and coagulation factors/blood transfusions in 13.3%). Diabetes was the highest represented comorbidity (20.8%), followed by metabolic syndrome ...Continue Reading

References

May 20, 2005·Journal of Medical Virology·Filippo AnsaldiGiancarlo Icardi
Aug 4, 2006·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A L ZignegoUNKNOWN Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV infection
Sep 26, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Anteo Di NapoliUNKNOWN Lazio Dialysis Registry
Nov 11, 2010·Antiviral Therapy·Ferruccio BoninoUNKNOWN Liver Stiffness Study Group 'Elastica' of the Italian Association for the Study of the Liver
Jun 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patrick MarcellinMario Rizzetto
Aug 3, 2014·Journal of Hepatology·Erin GowerHomie Razavi
Jan 7, 2015·Journal of Viral Hepatitis·V SaraswatE Gower
Apr 26, 2015·Journal of Hepatology·UNKNOWN European Association for Study of Liver
Aug 6, 2015·World Journal of Hepatology·Drosos E KarageorgopoulosSanjay Bhagani
Dec 15, 2015·Hepatology International·Kirat GillRobert Gish
Jan 29, 2016·World Journal of Gastroenterology : WJG·Cristina Stasi, Stefano Milani
Jan 28, 2017·World Journal of Gastroenterology : WJG·Cristina Stasi, Stefano Milani
Feb 19, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Timothy A Bach, Kathy Zaiken

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.